Avadel Pharmaceuticals PLC reports results for the quarter ended in June - Earnings Summary

Avadel Pharmaceuticals

09/08/2023 13:27

* Avadel Pharmaceuticals PLC  AVDL.OQ  reported a quarterly
adjusted loss of 83 cents​​ per share for the quarter ended in
June. The mean expectation of eight analysts for the quarter was
for a loss of 38 cents per share.
    * Revenue was $1.50 million​; analysts expected $631.14
thousand. 
    * Avadel Pharmaceuticals PLC's reported EPS for the quarter
was a
loss of 83 cents​.
    * The mean earnings estimate of analysts had fallen by
about 5.6%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Avadel Pharmaceuticals PLC shares had fallen by 18.0% this
quarter and gained 88.7% so far this year.
    * The company reported a quarterly loss of $64.43 million.
    * Wall Street's median 12-month price target for Avadel
Pharmaceuticals PLC is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 12:27 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.38          -0.83          Missed
 Mar. 31 2023      -0.38          -0.48          Missed
 Dec. 31 2022      -0.27          -0.46          Missed
 Sep. 30 2022      -0.25          -0.33          Missed